Cart

“A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Product	Price	Quantity	Subtotal
×	Gender Dysphoria in Pediatric and Transitional-Aged Youth Hospitalized for Suicidal Behaviors: A Cross-National Inpatient Study PDF	$40.00	Gender Dysphoria in Pediatric and Transitional-Aged Youth Hospitalized for Suicidal Behaviors: A Cross-National Inpatient Study PDF quantity	$40.00
×	Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone PDF	$40.00	Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone PDF quantity	$40.00
×	The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine PDF	$40.00	The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine PDF quantity	$40.00
×	A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder PDF	$40.00	A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Join Now

Cart totals

Subtotal	$160.00
Total	$160.00

Proceed to checkout

Cart

Cart totals

ELSEWHERE:

FOLLOW US:

Cart

Cart totals

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles